Brief: Corline Biomedical Q2 operating loss widens to SEK 2.0 mln
Aug 23 (Reuters) - CORLINE BIOMEDICAL AB CLBIO.ST
* Q2 NET SALES SEK 103,000 VERSUS SEK 367,000 YEAR AGO
* Q2 OPERATING LOSS SEK 2.0 MILLION VERSUS LOSS SEK 601,000
YEAR AGO
Source text for Eikon: ID:nGNE33wqKY
Further company coverage: CLBIO.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Corline Biomedical AB
See all newsBrief: Corline Biomedical Expectes Positive EBITDA In 2027
Brief: Corline Biomedical: Canada To Grant Kardium Up To C$31.25 Mln For Manufacturing Capacity Expansion
Brief: Corline Biomedical Q2 Net Sales Amount To SEK 4.7 Million
Brief: Corline Biomedical Partner Kardium Receives Approval For Globe Pulsed Field System In Canada
Brief: Corline Biomedical Q1 Result After Financial Items At SEK -2.5 Mln